{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:20:22Z","timestamp":1789755622425,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This project is a part of the EDCTP2 program supported by the European Union","award":["TMA2019CDF-2699-ULTRAPYRAPREG"],"award-info":[{"award-number":["TMA2019CDF-2699-ULTRAPYRAPREG"]}]},{"name":"Novartis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05260-6","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:49:01Z","timestamp":1740174541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intermittent screening using ultra-sensitive malaria rapid diagnostic test and treatment with pyronaridine-artesunate compared to standard preventive treatment with sulfadoxine-pyrimethamine for malaria prevention in pregnant women in Kinshasa, DRC"],"prefix":"10.1186","volume":"24","clinical-trial-number":[{"clinical-trial-number":"nct04783051","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Japhet Kabalu","family":"Tshiongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flory Luzolo","family":"Khote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Kabena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hypolite Muhindo","family":"Mavoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Kalonji-Mukendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landrine","family":"Luzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk D. F. H.","family":"Schallig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassoum","family":"Kayentao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra F.","family":"Mens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lutumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halidou","family":"Tinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivi","family":"Maketa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"5260_CR1","volume-title":"World malaria report 2023","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. World malaria report 2023. Geneva: World Health Organization; 2023."},{"key":"5260_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","volume":"7","author":"M Desai","year":"2007","unstructured":"Desai M, Ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7:93\u2013104.","journal-title":"Lancet Infect Dis"},{"key":"5260_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/tropej\/fmz068","volume":"66","author":"JM Thompson","year":"2020","unstructured":"Thompson JM, Eick SM, Dailey C, Dale AP, Mehta M, Nair A, et al. Relationship between pregnancy-associated malaria and adverse pregnancy outcomes: a systematic review and meta-analysis. J Trop Pediatr. 2020;66:327\u201338.","journal-title":"J Trop Pediatr"},{"key":"5260_CR4","volume-title":"Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). Geneva: World Health Organization; 2014."},{"key":"5260_CR5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1001\/jama.297.23.2603","volume":"297","author":"FO Ter Kuile","year":"2007","unstructured":"Ter Kuile FO, Van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007;297:2603\u201316.","journal-title":"JAMA"},{"key":"5260_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/20477724.2022.2128563","volume":"117","author":"RRD Nana","year":"2023","unstructured":"Nana RRD, Hawadak J, Foko LPK, Kumar A, Chaudhry S, Arya A, et al. Intermittent preventive treatment with sulfadoxine pyrimethamine for malaria: a global overview and challenges affecting optimal drug uptake in pregnant women. Pathog Glob Health. 2023;117:462\u201375.","journal-title":"Pathog Glob Health"},{"key":"5260_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/cid\/cir376","volume":"53","author":"WE Harrington","year":"2011","unstructured":"Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011;53:224\u201330.","journal-title":"Clin Infect Dis"},{"key":"5260_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/pathogens12060844","volume":"12","author":"CE Eboumbou Moukoko","year":"2023","unstructured":"Eboumbou Moukoko CE, Kojom Foko LP, Ayina A, Tornyigah B, Epote AR, Penda IC, et al. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnancy: low coverage and high prevalence of Plasmodium falciparum dhfr-dhps quintuple mutants as major challenges in Douala, an urban setting in Cameroon. Pathogens. 2023;12:844.","journal-title":"Pathogens"},{"key":"5260_CR9","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1038\/s41598-017-06708-9","volume":"7","author":"LC Okell","year":"2017","unstructured":"Okell LC, Griffin JT, Roper C. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci Rep. 2017;7:7389.","journal-title":"Sci Rep"},{"key":"5260_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1365-3156.2004.01239.x","volume":"9","author":"SG Staedke","year":"2004","unstructured":"Staedke SG, Sendagire H, Lamola S, Kamya MR, Dorsey G, Rosenthal PJ. Relationship between age, molecular markers, and response to sulphadoxine\u2013pyrimethamine treatment in Kampala. Uganda Trop Med Int Health. 2004;9:624\u20139.","journal-title":"Uganda Trop Med Int Health"},{"key":"5260_CR11","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S1473-3099(18)30064-1","volume":"18","author":"M Desai","year":"2018","unstructured":"Desai M, Hill J, Fernandes S, Walker P, Pell C, Gutman J, et al. Prevention of malaria in pregnancy. Lancet Infect Dis. 2018;18:e119\u201332.","journal-title":"Lancet Infect Dis"},{"key":"5260_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","volume":"29","author":"I Naidoo","year":"2013","unstructured":"Naidoo I, Roper C. Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria. Trends Parasitol. 2013;29:505\u201315.","journal-title":"Trends Parasitol"},{"key":"5260_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.105009","volume":"94","author":"NK Kayiba","year":"2021","unstructured":"Kayiba NK, Yobi DM, Tchakounang VRK, Mvumbi DM, Kabututu PZ, Devleesschauwer B, et al. Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo. Infect Genet Evol. 2021;94: 105009.","journal-title":"Infect Genet Evol"},{"key":"5260_CR14","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.4269\/ajtmh.17-0138","volume":"97","author":"E Ruizendaal","year":"2017","unstructured":"Ruizendaal E, Schallig HDFH, Scott S, Traore-Coulibaly M, Bradley J, Lompo P, et al. Evaluation of malaria screening during pregnancy with rapid diagnostic tests performed by community health workers in Burkina Faso. Am J Trop Med Hyg. 2017;97:1190\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"5260_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014425","volume":"5","author":"H Tagbor","year":"2010","unstructured":"Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS ONE. 2010;5: e14425.","journal-title":"PLoS ONE"},{"key":"5260_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12936-018-2394-2","volume":"17","author":"E Esu","year":"2018","unstructured":"Esu E, Berens-Riha N, Pritsch M, Nwachuku N, Loescher T, Meremikwu M. Intermittent screening and treatment with artemether\u2013lumefantrine versus intermittent preventive treatment with sulfadoxine\u2013pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria. Malar J. 2018;17:251.","journal-title":"Malar J"},{"key":"5260_CR17","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.eclinm.2021.101160","volume":"41","author":"JR Gutman","year":"2021","unstructured":"Gutman JR, Khairallah C, Stepniewska K, Tagbor H, Madanitsa M, Cairns M, et al. Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials. eClinicalMedicine. 2021;41:101160.","journal-title":"eClinicalMedicine."},{"key":"5260_CR18","doi-asserted-by":"publisher","first-page":"e00565","DOI":"10.1128\/JCM.00565-18","volume":"56","author":"J Landier","year":"2018","unstructured":"Landier J, Haohankhunnatham W, Das S, Konghahong K, Christensen P, Raksuansak J, et al. Operational performance of a Plasmodium falciparum ultrasensitive rapid diagnostic test for detection of asymptomatic infections in Eastern Myanmar. J Clin Microbiol. 2018;56:e00565-e618.","journal-title":"J Clin Microbiol"},{"key":"5260_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12936-018-2268-7","volume":"17","author":"S Das","year":"2018","unstructured":"Das S, Peck RB, Barney R, Jang IK, Kahn M, Zhu M, et al. Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood samples. Malar J. 2018;17:118.","journal-title":"Malar J"},{"key":"5260_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201769","volume":"13","author":"AM V\u00e1squez","year":"2018","unstructured":"V\u00e1squez AM, Medina AC, Tob\u00f3n-Casta\u00f1o A, Posada M, V\u00e9lez GJ, Campillo A, et al. Performance of a highly sensitive rapid diagnostic test (HS-RDT) for detecting malaria in peripheral and placental blood samples from pregnant women in Colombia. PLoS ONE. 2018;13: e0201769.","journal-title":"PLoS ONE"},{"key":"5260_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12936-023-04749-2","volume":"22","author":"J Kabalu Tshiongo","year":"2023","unstructured":"Kabalu Tshiongo J, Luzolo F, Kabena M, Kuseke L, Djimde M, Mitashi P, et al. Performance of ultra-sensitive malaria rapid diagnostic test to detect Plasmodium falciparum infection in pregnant women in Kinshasa, the Democratic Republic of the Congo. Malar J. 2023;22:322.","journal-title":"Malar J"},{"key":"5260_CR22","doi-asserted-by":"publisher","first-page":"e065295","DOI":"10.1136\/bmjopen-2022-065295","volume":"13","author":"M Djimde","year":"2023","unstructured":"Djimde M, Tshiongo JK, Muhindo HM, Tinto H, Sevene E, Traore M, et al. Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of P. falciparum uncomplicated malaria in African pregnant women (PYRAPREG): study protocol for a phase 3, non-inferiority, randomised open-label clinical trial. BMJ Open. 2023;13:e065295.","journal-title":"BMJ Open"},{"key":"5260_CR23","unstructured":"European Public Assessment Report (EPAR). Assessment Report; Pyramax nd. https:\/\/www.ema.europa.eu\/en\/documents\/outside-eu-assessment-report\/pyramax-public-assessment-report_en.pdf. Accessed 8 May 2024."},{"key":"5260_CR24","unstructured":"Programme National de Lutte contre le Paludisme, Minist\u00e8re de la Sant\u00e9 de la RDC Directives Nationales de Prise en charge du paludisme. Kinshasa, RDC: Minist\u00e8re de la Sant\u00e9 de la RDC. 2021."},{"key":"5260_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijid.2023.11.026","volume":"139","author":"G Mesia Kahunu","year":"2024","unstructured":"Mesia Kahunu G, Wellmann Thomsen S, Wellmann Thomsen L, Muhindo Mavoko H, Mitashi Mulopo P, Filtenborg Hocke E, et al. Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo. Int J Infect Dis. 2024;139:41\u20139.","journal-title":"Int J Infect Dis"},{"key":"5260_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1475-2875-13-132","volume":"13","author":"JR Matangila","year":"2014","unstructured":"Matangila JR, Lufuluabo J, Ibalanky AL, Inoc\u00eancio da Luz RA, Lutumba P, Van Geertruyden J-P. Asymptomatic Plasmodium falciparum infection is associated with anaemia in pregnancy and can be more cost-effectively detected by rapid diagnostic test than by microscopy in Kinshasa, Democratic Republic of the Congo. Malar J. 2014;13:132.","journal-title":"Malar J"},{"key":"5260_CR27","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1186\/s13063-022-06884-8","volume":"23","author":"V Maketa","year":"2022","unstructured":"Maketa V, Kabalu J, Kabena M, Luzolo F, Muhindo-Mavoko H, Schallig HDFH, et al. Comparison of intermittent screening (using ultra-sensitive malaria rapid diagnostic test) and treatment (using a newly registered antimalarial pyronaridine-artesunate-PYRAMAX\u00ae) to standard intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria in pregnant women living in endemic areas: ULTRAPYRAPREG. Trials. 2022;23:963.","journal-title":"Trials"},{"key":"5260_CR28","doi-asserted-by":"crossref","unstructured":"WANECAM. Pyronaridine\u2013artesunate or dihydroartemisinin\u2013piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial. Lancet. 2018;391:1378\u201390.","DOI":"10.1016\/S0140-6736(18)30291-5"},{"key":"5260_CR29","unstructured":"Fansidar Brand of Sulfadoxine and Pyrimethamine. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/18557slr015_fansidar_lbl.pdf. Accessed 1 August 2023."},{"key":"5260_CR30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12936-016-1627-5","volume":"15","author":"D Almond","year":"2016","unstructured":"Almond D, Madanitsa M, Mwapasa V, Kalilani-Phiri L, Webster J, ter Kuile F, et al. Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi. Malar J. 2016;15:574.","journal-title":"Malar J"},{"key":"5260_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(18)30732-1","volume":"19","author":"AM Van Eijk","year":"2019","unstructured":"Van Eijk AM, Larsen DA, Kayentao K, Koshy G, Slaughter DEC, Roper C, et al. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19:546\u201356.","journal-title":"Lancet Infect Dis"},{"key":"5260_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002124","volume":"13","author":"M Madanitsa","year":"2016","unstructured":"Madanitsa M, Kalilani L, Mwapasa V, van Eijk AM, Khairallah C, Ali D, et al. Scheduled intermittent screening with rapid diagnostic tests and treatment with dihydroartemisinin-piperaquine versus intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy in Malawi: an open-label randomized controlled trial. PLoS Med. 2016;13: e1002124.","journal-title":"PLoS Med"},{"key":"5260_CR33","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(15)00310-4","volume":"386","author":"M Desai","year":"2015","unstructured":"Desai M, Gutman J, L\u2019lanziva A, Otieno K, Juma E, Kariuki S, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin\u2013piperaquine versus intermittent preventive treatment with sulfadoxine\u2013pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet. 2015;386:2507\u201319.","journal-title":"Lancet"},{"key":"5260_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132247","volume":"10","author":"H Tagbor","year":"2015","unstructured":"Tagbor H, Cairns M, Bojang K, Coulibaly SO, Kayentao K, Williams J, et al. A non-inferiority, individually randomized trial of intermittent screening and treatment versus intermittent preventive treatment in the control of malaria in pregnancy. PLoS ONE. 2015;10: e0132247.","journal-title":"PLoS ONE"},{"key":"5260_CR35","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(18)32224-4","volume":"393","author":"R Kajubi","year":"2019","unstructured":"Kajubi R, Ochieng T, Kakuru A, Jagannathan P, Nakalembe M, Ruel T, et al. Monthly sulfadoxine\u2013pyrimethamine versus dihydroartemisinin\u2013piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. Lancet. 2019;393:1428\u201339.","journal-title":"Lancet"},{"key":"5260_CR36","first-page":"e942","volume":"8","author":"ME Roh","year":"2020","unstructured":"Roh ME, Kuile FOT, Rerolle F, Glymour MM, Shiboski S, Gosling R, et al. Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis. Lancet Infect Dis. 2020;8:e942\u201353.","journal-title":"Lancet Infect Dis"},{"key":"5260_CR37","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/cix026","volume":"64","author":"RM Chico","year":"2017","unstructured":"Chico RM, Chaponda EB, Ariti C, Chandramohan D. Sulfadoxine-pyrimethamine exhibits dose-response protection against adverse birth outcomes related to malaria and sexually transmitted and reproductive tract infections. Clin Infect Dis. 2017;64:1043\u201351.","journal-title":"Clin Infect Dis"},{"key":"5260_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1475-2875-12-70","volume":"12","author":"S Duparc","year":"2013","unstructured":"Duparc S, Borghini-Fuhrer I, Craft CJ, Arbe-Barnes S, Miller RM, Shin C-S, et al. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials. Malar J. 2013;12:70.","journal-title":"Malar J"},{"key":"5260_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12936-018-2578-9","volume":"17","author":"A Compaor\u00e9","year":"2018","unstructured":"Compaor\u00e9 A, Dierickx S, Jaiteh F, Nahum A, Bohissou TFE, Tinto H, et al. Fear and rumours regarding placental biopsies in a malaria-in-pregnancy trial in Benin. Malar J. 2018;17:425.","journal-title":"Malar J"},{"key":"5260_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000534","volume":"2","author":"C Mlandu","year":"2022","unstructured":"Mlandu C, Matsena-Zingoni Z, Musenge E. Trends and determinants of late antenatal care initiation in three East African countries, 2007\u20132016: a population based cross-sectional analysis. PLoS Glob Public Health. 2022;2: e0000534.","journal-title":"PLoS Glob Public Health"},{"key":"5260_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12936-020-3110-6","volume":"19","author":"VT Unwin","year":"2020","unstructured":"Unwin VT, Ahmed R, Noviyanti R, Puspitasari AM, Utami RAS, Trianty L, et al. Use of a highly-sensitive rapid diagnostic test to screen for malaria in pregnancy in Indonesia. Malar J. 2020;19:28.","journal-title":"Malar J"},{"key":"5260_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12936-023-04496-4","volume":"22","author":"NJ van Dijk","year":"2023","unstructured":"van Dijk NJ, Menting S, Wentink-Bonnema EMS, Broekhuizen-van Haaften PE, Withycombe E, Schallig HDFH, Mens PF. Laboratory evaluation of the miniature direct-on-blood PCR nucleic acid lateral flow immunoassay (mini-dbPCR-NALFIA), a simplified molecular diagnostic test for Plasmodium. Malar J. 2023;22:98.","journal-title":"Malar J"},{"key":"5260_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003669","volume":"18","author":"G Tona Lutete","year":"2021","unstructured":"Tona Lutete G, Mombo-Ngoma G, Assi S-B, Bigoga JD, Koukouikila-Koussounda F, Ntamabyaliro NY, et al. Pyronaridine\u2013artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: a single-arm, open-label, cohort event monitoring study. PLoS Med. 2021;18: e1003669.","journal-title":"PLoS Med"},{"key":"5260_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.987","volume":"10","author":"T Rouamba","year":"2022","unstructured":"Rouamba T, Sondo P, Yerbanga IW, Compaore A, Traore-Coulibaly M, Hien FS, et al. Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine\u2013artesunate in a rural health district in Burkina Faso. Pharmacol Res Perspect. 2022;10: e00987.","journal-title":"Pharmacol Res Perspect"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05260-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05260-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05260-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:49:10Z","timestamp":1740174550000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05260-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5260"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05260-6","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the National Ethics Committee of the DRC (approval reference: 169\/CNES\/BN\/PMMF\/2019 of March 13, 2020) and the Congolese Pharmaceutical Regulatory Authority (ACOREP) (approval reference: MS1253\/P\/DKK\/01096\/2020 of October 9, 2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}